Answers are grounded in this paper and cite their sources.
Lichen planopilaris (LPP) is a scarring alopecia encompassing three clinical subtypes that share overlapping features but distinct patterns of hair loss: frontal fibrosing alopecia (FFA), classic LPP (cLPP), and Graham–Little–Piccardi–Lassueur Syndrome (GLPLS). Despite increasing reports of familial clustering and emerging genetic research, the extent of heritability across LPP subtypes is unknown and the potential benefits of familial screening remain unclear. Therefore, a scoping review was conducted to consolidate data regarding familial disease and genetic associations, and assess implications for disease management. Data were extracted from 34 studies. Of the studies describing familial disease, 95 patients and 41 families were identified. FFA was the most commonly reported diagnosis, with mother–daughter and sister–sister pairs representing the most frequent familial relationships. Human leukocyte antigen genes were implicated in all three subtypes, although evidence was strongest for FFA, limited in cLPP, and restricted to familial observations in GLPLS. Genome-wide association studies (GWAS) of FFA implicated immune-related pathways, including antigen processing, immune activation, and immune homeostasis. Additional studies are required to expand GWAS to other LPP subtypes, functionally validate genetic findings, and determine whether routine familial screening is warranted. Nevertheless, current findings support a hypothetical, non-exclusive model in which genetic susceptibility contributes to hair follicle immune privilege disruption, permitting follicular damage and subsequent LPP development. Validation of this potential pathway may identify novel therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: